A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions

Published:2011-03 Issue:11 Volume:57 Page:1264-1270
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Lee Seung-Whan,Park Seong-Wook,Kim Young-Hak,Yun Sung-Cheol,Park Duk-Woo,Lee Cheol Whan,Kang Soo-Jin,Park Seung-Jung,Lee Jae-Hwan,Choi Si Wan,Seong In-Whan,Lee Nae-Hee,Cho Yoon Haeng,Shin Won-Yong,Lee Seung-Jin,Lee Se-Whan,Hyon Min-Su,Bang Duk-Won,Choi Young-Jin,Kim Hyun-Sook,Lee Bong-Ki,Lee Keun,Park Hoon-Ki,Park Chang-Bum,Lee Sang-Gon,Kim Min-Kyu,Park Kyoung-Ha,Park Woo-Jung

Funder

Korea Otsuka Pharmaceutical Co., Ltd

Cardiovascular Research Foundation

Cordis

Medtronic

Boston Scientific

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference11 articles.

1. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty;Tsuchikane;Circulation,1999

2. Coronary stent restenosis in patients treated with cilostazol;Douglas;Circulation,2005

3. Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial);Lee;Am J Cardiol,2007

4. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus: the DECLARE-DIABETES trial;Lee;J Am Coll Cardiol,2008

5. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between mono vs dual vs triple antiplatelet therapy in patients with ischemic heart disease undergoing PCI, a network meta-analysis;Current Problems in Cardiology;2024-11

2. The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis;International Journal of Molecular Sciences;2024-02-23

3. Cilostazol induces vasorelaxation through the activation of the eNOS/NO/cGMP pathway, prostanoids, AMPK, PKC, potassium channels, and calcium channels;Prostaglandins & Other Lipid Mediators;2023-12

4. Efficacy and safety of cilostazol-based triple antiplatelet therapy compared with clopidogrel-based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized, open-label, phase 4 trial;American Heart Journal;2023-11

5. A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease;Journal of Personalized Medicine;2022-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3